These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 22525390)

  • 1. Do inhaled corticosteroid/long-acting beta2-agonist fixed combinations provide superior clinical benefits compared with separate inhalers? A literature reappraisal.
    Barnes PJ; Nicolini G; Bizzi A; Spinola M; Singh D
    Allergy Asthma Proc; 2012; 33(2):140-4. PubMed ID: 22525390
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhaled corticosteroid and long-acting β2-agonist pharmacological profiles: effective asthma therapy in practice.
    Tamm M; Richards DH; Beghé B; Fabbri L
    Respir Med; 2012 Dec; 106 Suppl 1():S9-19. PubMed ID: 23273165
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Asthma control in patients receiving inhaled corticosteroid and long-acting beta2-agonist fixed combinations. A real-life study comparing dry powder inhalers and a pressurized metered dose inhaler extrafine formulation.
    Müller V; Gálffy G; Eszes N; Losonczy G; Bizzi A; Nicolini G; Chrystyn H; Tamási L
    BMC Pulm Med; 2011 Jul; 11():40. PubMed ID: 21762500
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhaled beclometasone dipropionate/formoterol fumarate extrafine fixed combination for the treatment of asthma.
    Crisafulli E; Zanini A; Pisi G; Pignatti P; Poli G; Scuri M; Chetta A
    Expert Rev Respir Med; 2016; 10(5):481-90. PubMed ID: 26938578
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Real-world effects of two inhaled corticosteroid/long-acting β₂-agonist combinations in the treatment of asthma.
    Yatera K; Yamasaki K; Nishida C; Noguchi S; Oda K; Akata K; Nagata S; Kawanami Y; Kawanami T; Ishimoto H; Mukae H
    J Asthma; 2014 Sep; 51(7):762-8. PubMed ID: 24654703
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel functional imaging of changes in small airways of patients treated with extrafine beclomethasone/formoterol.
    Vos W; De Backer J; Poli G; De Volder A; Ghys L; Van Holsbeke C; Vinchurkar S; De Backer L; De Backer W
    Respiration; 2013; 86(5):393-401. PubMed ID: 23595105
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combination inhalers containing inhaled corticosteroids and long-acting beta2-agonists: improved clinical efficacy and dosing options in patients with asthma.
    Ankerst J
    J Asthma; 2005 Nov; 42(9):715-24. PubMed ID: 16316864
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fluticasone propionate/formoterol fumarate in fixed-dose combination for the treatment of asthma.
    Price D; Hillyer EV
    Expert Rev Respir Med; 2014 Jun; 8(3):275-91. PubMed ID: 24802285
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Economic evaluation of BDP/formoterol fixed vs two single inhalers in asthma treatment.
    Brüggenjürgen B; Ezzat N; Kardos P; Buhl R
    Allergy; 2010 Sep; 65(9):1108-15. PubMed ID: 20121768
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhaled beclometasone dipropionate/formoterol extra-fine fixed combination in the treatment of asthma: evidence and future perspectives.
    Fabbri LM; Nicolini G; Olivieri D; Papi A
    Expert Opin Pharmacother; 2008 Feb; 9(3):479-90. PubMed ID: 18220498
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Real life clinical study design supporting the effectiveness of extra-fine inhaled beclomethasone/formoterol at the level of small airways of asthmatics.
    Popov TA; Petrova D; Kralimarkova TZ; Ivanov Y; Popova T; Peneva M; Odzhakova T; Ilieva Y; Yakovliev P; Lazarova T; Georgiev O; Hodzhev V; Hodzheva E; Staevska MT; Dimitrov VD
    Pulm Pharmacol Ther; 2013 Dec; 26(6):624-9. PubMed ID: 23769863
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fixed-Dose Combination Inhalers.
    Cazzola M; Matera MG
    Handb Exp Pharmacol; 2017; 237():117-129. PubMed ID: 27783268
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antagonism of long-acting beta2-adrenoceptor agonism.
    Lipworth BJ
    Br J Clin Pharmacol; 2002 Sep; 54(3):231-45. PubMed ID: 12236842
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lung function and asthma control with beclomethasone and formoterol in a single inhaler.
    Huchon G; Magnussen H; Chuchalin A; Dymek L; Gonod FB; Bousquet J
    Respir Med; 2009 Jan; 103(1):41-9. PubMed ID: 18977646
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of persistent asthma with Symbicort (budesonide/formoterol inhalation aerosol): an inhaled corticosteroid and long-acting beta2-adrenergic agonist in one pressurized metered-dose inhaler.
    Berger WE; Noonan MJ
    J Asthma; 2010 May; 47(4):447-59. PubMed ID: 20528601
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fluticasone/formoterol: a new single-aerosol combination therapy for patients with asthma.
    Dissanayake S; Grothe B; Kaiser K
    Respir Med; 2012 Dec; 106 Suppl 1():S20-8. PubMed ID: 23273163
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-dose beclometasone dipropionate/formoterol fumarate in fixed-dose combination for the treatment of asthma.
    Corradi M; Spinola M; Petruzzelli S; Kuna P
    Ther Adv Respir Dis; 2016 Oct; 10(5):492-502. PubMed ID: 27340255
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Single maintenance and reliever therapy (SMART) for asthma.
    Drug Ther Bull; 2011 Nov; 49(11):126-9. PubMed ID: 22074945
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mometasone furoate/formoterol in the treatment of persistent asthma.
    Berger WE
    Expert Rev Respir Med; 2011 Dec; 5(6):739-46. PubMed ID: 22082160
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Real-life effectiveness of extrafine beclometasone dipropionate/formoterol in adults with persistent asthma according to smoking status.
    Brusselle G; Peché R; Van den Brande P; Verhulst A; Hollanders W; Bruhwyler J
    Respir Med; 2012 Jun; 106(6):811-9. PubMed ID: 22357130
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.